Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine besylate bioequivalence study under fasting and fed conditions in healthy Chinese adults
ChiCTR1800015238Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amlodipine in hypertension (HTN) and coronary arteriosclerosis (4 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Cmax and AUC0-t. Started Mar 2018; status: recruiting.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800015238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015238.